These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27552286)

  • 1. FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.
    Huang H; McIntosh AL; Martin GG; Landrock D; Chung S; Landrock KK; Dangott LJ; Li S; Kier AB; Schroeder F
    Biochemistry; 2016 Sep; 55(37):5243-55. PubMed ID: 27552286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FABP-1 gene ablation impacts brain endocannabinoid system in male mice.
    Martin GG; Chung S; Landrock D; Landrock KK; Huang H; Dangott LJ; Peng X; Kaczocha M; Seeger DR; Murphy EJ; Golovko MY; Kier AB; Schroeder F
    J Neurochem; 2016 Aug; 138(3):407-22. PubMed ID: 27167970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Fabp1 Gene Ablation on Uptake and Degradation of Endocannabinoids in Mouse Hepatocytes.
    McIntosh AL; Huang H; Landrock D; Martin GG; Li S; Kier AB; Schroeder F
    Lipids; 2018 Jun; 53(6):561-580. PubMed ID: 30203570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sterol Carrier Protein-2/Sterol Carrier Protein-x/Fatty Acid Binding Protein-1 Ablation Impacts Response of Brain Endocannabinoid to High-Fat Diet.
    Martin GG; Seeger DR; McIntosh AL; Milligan S; Chung S; Landrock D; Dangott LJ; Golovko MY; Murphy EJ; Kier AB; Schroeder F
    Lipids; 2019 Oct; 54(10):583-601. PubMed ID: 31487051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Δ
    McIntosh AL; Martin GG; Huang H; Landrock D; Kier AB; Schroeder F
    J Lipid Res; 2018 Apr; 59(4):646-657. PubMed ID: 29414765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.
    Martin GG; Chung S; Landrock D; Landrock KK; Dangott LJ; Peng X; Kaczocha M; Murphy EJ; Kier AB; Schroeder F
    Lipids; 2016 Sep; 51(9):1007-20. PubMed ID: 27450559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat.
    Martin GG; Seeger DR; McIntosh AL; Chung S; Milligan S; Landrock D; Dangott LJ; Golovko MY; Murphy EJ; Kier AB; Schroeder F
    Arch Biochem Biophys; 2018 Jul; 650():93-102. PubMed ID: 29763591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid Interaction with Human FABP1: Impact of the T94A Variant.
    Martin GG; Huang H; McIntosh AL; Kier AB; Schroeder F
    Biochemistry; 2017 Sep; 56(38):5147-5159. PubMed ID: 28853554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabp1 gene ablation inhibits high-fat diet-induced increase in brain endocannabinoids.
    Martin GG; Landrock D; Chung S; Dangott LJ; Seeger DR; Murphy EJ; Golovko MY; Kier AB; Schroeder F
    J Neurochem; 2017 Jan; 140(2):294-306. PubMed ID: 27861894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System.
    Martin GG; Landrock D; Dangott LJ; McIntosh AL; Kier AB; Schroeder F
    Lipids; 2018 Jan; 53(1):27-40. PubMed ID: 29488637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.
    Schroeder F; McIntosh AL; Martin GG; Huang H; Landrock D; Chung S; Landrock KK; Dangott LJ; Li S; Kaczocha M; Murphy EJ; Atshaves BP; Kier AB
    Lipids; 2016 Jun; 51(6):655-76. PubMed ID: 27117865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Functional Interaction of Δ
    Huang H; McIntosh AL; Martin GG; Dangott LJ; Kier AB; Schroeder F
    Biochemistry; 2018 Oct; 57(41):6027-6042. PubMed ID: 30232874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet.
    Martin GG; Landrock D; Chung S; Dangott LJ; McIntosh AL; Mackie JT; Kier AB; Schroeder F
    J Lipid Res; 2017 Nov; 58(11):2114-2126. PubMed ID: 28972119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.
    Milligan S; Martin GG; Landrock D; McIntosh AL; Mackie JT; Schroeder F; Kier AB
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):323-338. PubMed ID: 29307784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice.
    Nicolussi S; Viveros-Paredes JM; Gachet MS; Rau M; Flores-Soto ME; Blunder M; Gertsch J
    Pharmacol Res; 2014 Feb; 80():52-65. PubMed ID: 24412246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FABP1 controls hepatic transport and biotransformation of Δ
    Elmes MW; Prentis LE; McGoldrick LL; Giuliano CJ; Sweeney JM; Joseph OM; Che J; Carbonetti GS; Studholme K; Deutsch DG; Rizzo RC; Glynn SE; Kaczocha M
    Sci Rep; 2019 May; 9(1):7588. PubMed ID: 31110286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of
    Storey SM; Huang H; McIntosh AL; Martin GG; Kier AB; Schroeder F
    J Lipid Res; 2017 Jun; 58(6):1153-1165. PubMed ID: 28411199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of fatty acid-binding proteins (fabps) from Japanese seabass (Lateolabraxjaponicus) liver, and their gene expressions in response to dietary arachidonic acid (ARA).
    Xu H; Zhang Y; Wang C; Wei Y; Zheng K; Liang M
    Comp Biochem Physiol B Biochem Mol Biol; 2017 Feb; 204():27-34. PubMed ID: 27871949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
    Kim J; Watkins BA
    J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.